Skip to main content
. 2006 Jul 28;103(32):12103–12108. doi: 10.1073/pnas.0604404103

Table 3.

Peripheral insulin effects in IRS-1 Gly/Gly and X/Arg subjects (hyperinsulinemic euglycemic clamp)

Time period Steady-state plasma glucose, mmol/liter
Steady-state plasma insulin, pmol/liter
Glucose infusion rate, μmol·kg−1·min−1
Insulin sensitivity, μmol·kg−1·min−1pmol−1·liter
Gly/Gly X/Arg Gly/Gly X/Arg Gly/Gly X/Arg Gly/Gly X/Arg
Basal 4.73 ± 0.06 4.50 ± 0.17 47 ± 5 41 ± 10
First step 5.09 ± 0.09 5.12 ± 0.13 97 ± 12 119 ± 18 7.8 ± 1.1 7.5 ± 1.1* 0.10 ± 0.02 0.08 ± 0.02
Second step 4.72 ± 0.08 4.88 ± 0.19 424 ± 32 406 ± 40 39.3 ± 5.0 29.8 ± 3.9 0.10 ± 0.02 0.09 ± 0.02§

∗, P = 0.86;

†, P = 0.44;

‡, P = 0.24;

§, P = 0.56.